Generics - Gastro-intestinals, Markets & Marketing


Popular Filters

Amneal debuts generic Esomeprazole strontium in USA


Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

Actavis debuts generic Pariet in Europe; Impax challenges Opana ER patent


Switzerland-based generic drugmaker Actavis, now wholly-owned by the USA's Watson Pharmaceuticals (NYSE:…

ActavisEndo PharmaceuticalsGastro-intestinalsGenericsGrunenthalImpax LaboratoriesJohnson & JohnsonMarkets & MarketingNeurologicalNorth AmericaOpana ERParietPatentsThoRx LabsWatson Pharmaceuticals

Researchers bust a gut to improve gastrointestinal disorders market


Drugs to treat gastrointestinal disorders are due to see a significant price drop, as patents run out…

Gastro-intestinalsGenericsMarkets & MarketingPharmaceutical

Uptake of biosimilars will see Remicade and Humira sales decline in 2017


The TNF-alpha inhibitors infliximab (Janssen Biotech/Merck/Mitsubishi Tanabe's Remicade) and adalimumab…

BiotechnologyGastro-intestinalsGenericsGlobalHumiraMarkets & MarketingRemicade

Watson debuts generic Nexium in Europe; Mylan launches Amidate copy in USA


US generics firm Watson Pharmaceuticals (NYSE: WPI) said yesterday that its third-party business Specifar…

AmidateAstraZenecaEuropeGastro-intestinalsGenericsHospiraMarkets & MarketingMylan LaboratoriesNeurologicalNexiumNorth AmericaRegulationWatson Pharmaceuticals

Back to top